PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection

Introduction The NHS Bowel Cancer Screening Programme (BCSP) in England has used the guaiac-based faecal occult blood test (gFOBt) since 2006. Test positivity is higher during the first 5 days after sample collection. Methods The gFOBt kits used by the BCSP have six windows (three pairs) lined with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gut 2013-06, Vol.62 (Suppl 1), p.A138-A138
Hauptverfasser: Seaman, H E, Snowball, J M, Halloran, S P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A138
container_issue Suppl 1
container_start_page A138
container_title Gut
container_volume 62
creator Seaman, H E
Snowball, J M
Halloran, S P
description Introduction The NHS Bowel Cancer Screening Programme (BCSP) in England has used the guaiac-based faecal occult blood test (gFOBt) since 2006. Test positivity is higher during the first 5 days after sample collection. Methods The gFOBt kits used by the BCSP have six windows (three pairs) lined with guaiac-impregnated philtre paper. The screening participant is asked to apply two faecal samples from three separate stools. The samples usually arrive dry at the laboratory, which is likely to reduce the degree of haemoglobin (Hb) degradation and provide the best opportunity to detect bleeding. BCSP policy is that every kit is logged on the day of receipt and read as soon as possible thereafter. BCSP Southern Hub data from the Bowel Cancer Screening System (BCSS) for 01/2008–07/2012 were analysed for subjects aged 60–69 years completing the first prevalent round of screening. The interval between each sample date and the date the sample was analysed (elapsed time) was calculated. Spot positivity was assessed by elapsed time, stratified by sex. Clinical outcomes were extracted from BCSS for subjects who had a positive gFOBt result. The relationship between positivity, elapsed time and clinical outcomes was examined. Results During the period of observation, nearly 1.2 million kits were returned to the Hub and 92% were read within five days of the last sample collection. For samples analysed one day after the last sample collection, spot positivity was 2.7% for women and 3.8% for men. Positivity declined thereafter until it reached a steady level at day 5 (women 1.3%; men 2.0%). Positivity for the most recently collected sample (usually spots 5 and 6) was slightly higher than for the spots collected earlier. There were 20,408 subjects (8,343 women; 12,065 men) who accepted further investigation. The outcome of those investigations was not associated with elapsed time between faecal sampling and test kit reading; the proportion of cancers, high-, intermediate- and low-risk adenomas was fairly constant as elapsed time increased. Conclusion The higher positivity associated with a shorter elapsed time did not appear to be associated with more false-positive tests. A number of factors may contribute to the pattern of positivity observed: (a) vegetable peroxidases present in the diet cause short term increases in gFOBt positivity; (b) faecal Hb denatures gradually before analysis, and (c) screening invitees worried about their health may return test kits more rapidly t
doi_str_mv 10.1136/gutjnl-2013-304907.310
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2038762686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2038762686</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2030-db20fd73884d290b1bb095e48310fd62ab700aea505e0e7ae1eb8639b6d26d713</originalsourceid><addsrcrecordid>eNqNUE1PGzEQtaoiNQ39C5Wlng3j9a7tPaJAAlIEEaIfN8vOeoPTzTq1ndDceuGP8ktwtIhzL_OkmffmzTyEvlI4o5Tx89UurfuOFEAZYVDWIM4YhQ9oREsuCSuk_IhGAFSQSpT1J_Q5xjUASFnTEeoWP68IFPTl3_NFj2_6vY3JrXRyvseuTx5fu9UjnrXeJLzw0SW3d-mAL3fB9SucHi2euhBTrnuLL_Uh4tZ3nX86TqPebDuLJ7lhl8eNp-ik1V20X95wjL5Prx4m12R-N7uZXMyJKYABaTK0jWBSlk1Rg6HGQF3ZUua32oYX2ggAbXUFlQUrtKXWSM5qw5uCN4KyMfo27N0G_2eXP1Jrvwt9tlTZQApe8MwfIz6wlsHHGGyrtsFtdDgoCuqYrBqSVcdk1ZCsyidkIRmELib7912lw2_FBROVuv0xUfP7OUzvWaV-ZT4d-Gaz_l-PV17ejQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038762686</pqid></control><display><type>article</type><title>PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection</title><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Seaman, H E ; Snowball, J M ; Halloran, S P</creator><creatorcontrib>Seaman, H E ; Snowball, J M ; Halloran, S P</creatorcontrib><description>Introduction The NHS Bowel Cancer Screening Programme (BCSP) in England has used the guaiac-based faecal occult blood test (gFOBt) since 2006. Test positivity is higher during the first 5 days after sample collection. Methods The gFOBt kits used by the BCSP have six windows (three pairs) lined with guaiac-impregnated philtre paper. The screening participant is asked to apply two faecal samples from three separate stools. The samples usually arrive dry at the laboratory, which is likely to reduce the degree of haemoglobin (Hb) degradation and provide the best opportunity to detect bleeding. BCSP policy is that every kit is logged on the day of receipt and read as soon as possible thereafter. BCSP Southern Hub data from the Bowel Cancer Screening System (BCSS) for 01/2008–07/2012 were analysed for subjects aged 60–69 years completing the first prevalent round of screening. The interval between each sample date and the date the sample was analysed (elapsed time) was calculated. Spot positivity was assessed by elapsed time, stratified by sex. Clinical outcomes were extracted from BCSS for subjects who had a positive gFOBt result. The relationship between positivity, elapsed time and clinical outcomes was examined. Results During the period of observation, nearly 1.2 million kits were returned to the Hub and 92% were read within five days of the last sample collection. For samples analysed one day after the last sample collection, spot positivity was 2.7% for women and 3.8% for men. Positivity declined thereafter until it reached a steady level at day 5 (women 1.3%; men 2.0%). Positivity for the most recently collected sample (usually spots 5 and 6) was slightly higher than for the spots collected earlier. There were 20,408 subjects (8,343 women; 12,065 men) who accepted further investigation. The outcome of those investigations was not associated with elapsed time between faecal sampling and test kit reading; the proportion of cancers, high-, intermediate- and low-risk adenomas was fairly constant as elapsed time increased. Conclusion The higher positivity associated with a shorter elapsed time did not appear to be associated with more false-positive tests. A number of factors may contribute to the pattern of positivity observed: (a) vegetable peroxidases present in the diet cause short term increases in gFOBt positivity; (b) faecal Hb denatures gradually before analysis, and (c) screening invitees worried about their health may return test kits more rapidly than others and a proportion of those individuals will be found to have colorectal cancer and related disease. None of those factors alone can account for the marked elevation in the ‘early positivity rate’ and further studies are required to elucidate the reasons for this effect. Disclosure of Interest None Declared.</description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>DOI: 10.1136/gutjnl-2013-304907.310</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Cancer ; Cancer screening ; Clinical outcomes ; Colorectal cancer ; Colorectal carcinoma ; Hemoglobin ; Intestine ; Medical screening</subject><ispartof>Gut, 2013-06, Vol.62 (Suppl 1), p.A138-A138</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 © 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://gut.bmj.com/content/62/Suppl_1/A138.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://gut.bmj.com/content/62/Suppl_1/A138.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Seaman, H E</creatorcontrib><creatorcontrib>Snowball, J M</creatorcontrib><creatorcontrib>Halloran, S P</creatorcontrib><title>PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection</title><title>Gut</title><addtitle>Gut</addtitle><description>Introduction The NHS Bowel Cancer Screening Programme (BCSP) in England has used the guaiac-based faecal occult blood test (gFOBt) since 2006. Test positivity is higher during the first 5 days after sample collection. Methods The gFOBt kits used by the BCSP have six windows (three pairs) lined with guaiac-impregnated philtre paper. The screening participant is asked to apply two faecal samples from three separate stools. The samples usually arrive dry at the laboratory, which is likely to reduce the degree of haemoglobin (Hb) degradation and provide the best opportunity to detect bleeding. BCSP policy is that every kit is logged on the day of receipt and read as soon as possible thereafter. BCSP Southern Hub data from the Bowel Cancer Screening System (BCSS) for 01/2008–07/2012 were analysed for subjects aged 60–69 years completing the first prevalent round of screening. The interval between each sample date and the date the sample was analysed (elapsed time) was calculated. Spot positivity was assessed by elapsed time, stratified by sex. Clinical outcomes were extracted from BCSS for subjects who had a positive gFOBt result. The relationship between positivity, elapsed time and clinical outcomes was examined. Results During the period of observation, nearly 1.2 million kits were returned to the Hub and 92% were read within five days of the last sample collection. For samples analysed one day after the last sample collection, spot positivity was 2.7% for women and 3.8% for men. Positivity declined thereafter until it reached a steady level at day 5 (women 1.3%; men 2.0%). Positivity for the most recently collected sample (usually spots 5 and 6) was slightly higher than for the spots collected earlier. There were 20,408 subjects (8,343 women; 12,065 men) who accepted further investigation. The outcome of those investigations was not associated with elapsed time between faecal sampling and test kit reading; the proportion of cancers, high-, intermediate- and low-risk adenomas was fairly constant as elapsed time increased. Conclusion The higher positivity associated with a shorter elapsed time did not appear to be associated with more false-positive tests. A number of factors may contribute to the pattern of positivity observed: (a) vegetable peroxidases present in the diet cause short term increases in gFOBt positivity; (b) faecal Hb denatures gradually before analysis, and (c) screening invitees worried about their health may return test kits more rapidly than others and a proportion of those individuals will be found to have colorectal cancer and related disease. None of those factors alone can account for the marked elevation in the ‘early positivity rate’ and further studies are required to elucidate the reasons for this effect. Disclosure of Interest None Declared.</description><subject>Cancer</subject><subject>Cancer screening</subject><subject>Clinical outcomes</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Hemoglobin</subject><subject>Intestine</subject><subject>Medical screening</subject><issn>0017-5749</issn><issn>1468-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNUE1PGzEQtaoiNQ39C5Wlng3j9a7tPaJAAlIEEaIfN8vOeoPTzTq1ndDceuGP8ktwtIhzL_OkmffmzTyEvlI4o5Tx89UurfuOFEAZYVDWIM4YhQ9oREsuCSuk_IhGAFSQSpT1J_Q5xjUASFnTEeoWP68IFPTl3_NFj2_6vY3JrXRyvseuTx5fu9UjnrXeJLzw0SW3d-mAL3fB9SucHi2euhBTrnuLL_Uh4tZ3nX86TqPebDuLJ7lhl8eNp-ik1V20X95wjL5Prx4m12R-N7uZXMyJKYABaTK0jWBSlk1Rg6HGQF3ZUua32oYX2ggAbXUFlQUrtKXWSM5qw5uCN4KyMfo27N0G_2eXP1Jrvwt9tlTZQApe8MwfIz6wlsHHGGyrtsFtdDgoCuqYrBqSVcdk1ZCsyidkIRmELib7912lw2_FBROVuv0xUfP7OUzvWaV-ZT4d-Gaz_l-PV17ejQU</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Seaman, H E</creator><creator>Snowball, J M</creator><creator>Halloran, S P</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201306</creationdate><title>PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection</title><author>Seaman, H E ; Snowball, J M ; Halloran, S P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2030-db20fd73884d290b1bb095e48310fd62ab700aea505e0e7ae1eb8639b6d26d713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Cancer</topic><topic>Cancer screening</topic><topic>Clinical outcomes</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Hemoglobin</topic><topic>Intestine</topic><topic>Medical screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seaman, H E</creatorcontrib><creatorcontrib>Snowball, J M</creatorcontrib><creatorcontrib>Halloran, S P</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seaman, H E</au><au>Snowball, J M</au><au>Halloran, S P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>2013-06</date><risdate>2013</risdate><volume>62</volume><issue>Suppl 1</issue><spage>A138</spage><epage>A138</epage><pages>A138-A138</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><abstract>Introduction The NHS Bowel Cancer Screening Programme (BCSP) in England has used the guaiac-based faecal occult blood test (gFOBt) since 2006. Test positivity is higher during the first 5 days after sample collection. Methods The gFOBt kits used by the BCSP have six windows (three pairs) lined with guaiac-impregnated philtre paper. The screening participant is asked to apply two faecal samples from three separate stools. The samples usually arrive dry at the laboratory, which is likely to reduce the degree of haemoglobin (Hb) degradation and provide the best opportunity to detect bleeding. BCSP policy is that every kit is logged on the day of receipt and read as soon as possible thereafter. BCSP Southern Hub data from the Bowel Cancer Screening System (BCSS) for 01/2008–07/2012 were analysed for subjects aged 60–69 years completing the first prevalent round of screening. The interval between each sample date and the date the sample was analysed (elapsed time) was calculated. Spot positivity was assessed by elapsed time, stratified by sex. Clinical outcomes were extracted from BCSS for subjects who had a positive gFOBt result. The relationship between positivity, elapsed time and clinical outcomes was examined. Results During the period of observation, nearly 1.2 million kits were returned to the Hub and 92% were read within five days of the last sample collection. For samples analysed one day after the last sample collection, spot positivity was 2.7% for women and 3.8% for men. Positivity declined thereafter until it reached a steady level at day 5 (women 1.3%; men 2.0%). Positivity for the most recently collected sample (usually spots 5 and 6) was slightly higher than for the spots collected earlier. There were 20,408 subjects (8,343 women; 12,065 men) who accepted further investigation. The outcome of those investigations was not associated with elapsed time between faecal sampling and test kit reading; the proportion of cancers, high-, intermediate- and low-risk adenomas was fairly constant as elapsed time increased. Conclusion The higher positivity associated with a shorter elapsed time did not appear to be associated with more false-positive tests. A number of factors may contribute to the pattern of positivity observed: (a) vegetable peroxidases present in the diet cause short term increases in gFOBt positivity; (b) faecal Hb denatures gradually before analysis, and (c) screening invitees worried about their health may return test kits more rapidly than others and a proportion of those individuals will be found to have colorectal cancer and related disease. None of those factors alone can account for the marked elevation in the ‘early positivity rate’ and further studies are required to elucidate the reasons for this effect. Disclosure of Interest None Declared.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><doi>10.1136/gutjnl-2013-304907.310</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 2013-06, Vol.62 (Suppl 1), p.A138-A138
issn 0017-5749
1468-3288
language eng
recordid cdi_proquest_journals_2038762686
source BMJ Journals - NESLi2; PubMed Central
subjects Cancer
Cancer screening
Clinical outcomes
Colorectal cancer
Colorectal carcinoma
Hemoglobin
Intestine
Medical screening
title PWE-021 An Investigation into High Gfobt Positivity During the First Five Days following sample Collection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A40%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PWE-021%E2%80%85An%20Investigation%20into%20High%20Gfobt%20Positivity%20During%20the%20First%20Five%20Days%20following%20sample%20Collection&rft.jtitle=Gut&rft.au=Seaman,%20H%20E&rft.date=2013-06&rft.volume=62&rft.issue=Suppl%201&rft.spage=A138&rft.epage=A138&rft.pages=A138-A138&rft.issn=0017-5749&rft.eissn=1468-3288&rft_id=info:doi/10.1136/gutjnl-2013-304907.310&rft_dat=%3Cproquest_cross%3E2038762686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038762686&rft_id=info:pmid/&rfr_iscdi=true